Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Research ArticleQUARTERLY COLUMNS
Open Access

Hirayama Disease in an Adolescent Male With Right Hand Weakness and Muscle Wasting

Julian Llano, Neil U. Lall, Lamar Davis and Andrew J. Steven
Ochsner Journal June 2020, 20 (2) 117-120; DOI: https://doi.org/10.31486/toj.19.0045
Julian Llano
1Universidad CES, Medellín, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil U. Lall
2Department of Radiology, Emory University School of Medicine, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lamar Davis
3Department of Pediatrics, Ochsner Clinic Foundation, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Steven
4Department of Radiology, Ochsner Clinic Foundation, New Orleans, LA
5The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

INTRODUCTION

Hirayama disease, also known as monomelic amyotrophy1 or juvenile muscular atrophy of the upper extremity,2,3 is a rare neurologic condition that involves the inferior motor neurons1 and commonly affects the C7 to T1 spinal nerves and their myotomes.4 Hirayama first described this type of cervical myelopathy in 1959, stating that it was clinically differentiated from the other known types of motor neuron disease.5

Characterized by insidious onset,1,6,7 this disease, commonly associated with Asian descent, has a male predominance ranging from 7:14,6 to 20:1,7,8 depending on the population, and is typically diagnosed during the second and third decades of life.1,6,8,9 Although the exact pathophysiology is unknown, one theory is an imbalance between the growth of the vertebral column and that of the spinal canal contents,7 a discrepancy that results in forward displacement of the posterior dural sac with neck flexion,10 leading to compression and injury of the spinal cord with posterior damage to the anterior horn cells.6 Hirayama disease commonly presents with unilateral or bilateral asymmetric weakness and muscle wasting of the C7 to T1 myotomes, with characteristic sparing of the brachioradialis muscle and without associated sensory loss.6

HISTORY AND CASE REPORT

A 14-year-old male with no significant medical history presented to the pediatric neurology clinic complaining of 7 to 8 months of progressive inability to straighten his wrists. He noted problems with his handwriting, holding utensils, texting, and manipulating the joysticks of his Xbox controller. The patient additionally reported having cramps, numbness, tingling, and shooting pain in his hands associated with neck flexion. The patient's mother described an episode of neck trauma that had occurred approximately 1 year prior to presentation, but the patient had had no significant symptoms at that time.

Physical examination revealed atrophy of the hypothenar eminence and the first dorsal interosseous muscle bilaterally. Weakness was present in both upper extremities, asymmetrically affecting the right side. Additionally, a very low amplitude tremor was elicited with finger extension, consistent with minipolymyoclonus. No sensory deficits were identified, and no abnormal findings were noted in the examination of the lower extremities.

RADIOGRAPHIC APPEARANCE AND TREATMENT

Nerve conduction studies (NCSs) revealed reduction of the compound muscle action potential (CMAP) amplitudes of the bilateral ulnar nerves. Electromyography (EMG) showed active denervation of the right dorsal interosseous and questionable denervation in the right triceps, suggesting a chronic neurogenic process affecting primarily C8 and T1 on the right with partial C7 involvement.

Initial cervical spine magnetic resonance imaging (MRI) showed thinning of the cervical cord centered at the C5-C6 level. Small foci of increased T2 signal intensity were present within the central aspect of the cord in the region of the anterior horn cells extending from C3 to C7 (Figure 1). No associated compressive lesion was identified in neutral position.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Routine neutral position cervical spine magnetic resonance imaging. (A) Sagittal T2-weighted image shows thinning of the spinal cord at the C5-C6 level (white arrow). (B) Axial T2-weighted image shows 2 foci of central paramedian hyperintensity, also known as snake-eye appearance (dashed arrow).

The patient returned for additional MRI with flexion positioning. Flexion views showed expansion of the posterior epidural space from C3 through C7, measuring up to 0.5 cm in thickness. The ventral dural displacement resulted in complete effacement of the cerebrospinal fluid within the spinal canal and localized mass effect on the spinal cord (Figure 2). The appearance confirmed the diagnosis of Hirayama disease.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Flexion position cervical spine magnetic resonance imaging. (A) Sagittal T2-weighted short tau inversion recovery (STIR) image and (B) sagittal T2*-gradient recalled echo (GRE) image reveal expansion of the posterior cervical epidural space with hyperintense fluid signal and T2 hypointense epidural flow voids from C3 to C7 (dashed arrows in views A and B), ventral displacement of the dura mater, and compression of the spinal cord. (C) Axial 3-dimensional T2 image shows a compressed thecal sac with the classic snake-eye appearance due to compression of the spinal cord (upper arrows). The posterior cervical epidural space is also enlarged with fluid signal and anterior displacement of the dura mater (lower arrows).

The patient was treated conservatively with a cervical collar to be worn at all times, and a follow-up MRI was scheduled 3 months later.

DISCUSSION

Hirayama disease, although a rare entity, should be part of the differential diagnosis for young male patients11 complaining of upper extremity weakness associated with muscle wasting. Although familial presentations have been described, the disease is typically sporadic as in this case.3,8,9

Because Hirayama disease is a rare disease, its etiology and pathophysiology are not well understood. The cervical myelopathy appears to result from anterior displacement of the posterior cervical dura compressing the spinal cord against the vertebral bodies.6,10 This displacement is theorized to be caused by an imbalance between the growth of the vertebral column and the growth of the spinal canal contents.7 Another theory is that the increased laxity of the dura mater, anchored superiorly at C2-C3, allows for increased cord movement and concomitant anterior displacement with neck flexion, resulting in repetitive cervical microtrauma that leads to microischemia of the anterior horn cells.12

Hirayama disease often has an insidious onset of progressive weakness and muscular wasting of the upper extremity.6,9,13 The disease appears to be self-limiting, reaching a stable state approximately 3 to 5 years after its onset,4,14 a characteristic that differentiates this entity from other known motor neuron diseases.8 Although it is often unilateral, affecting the left side more than the right,15 Hirayama disease also presents bilaterally (symmetrically or asymmetrically) in 10% of cases.6,12,16 Our patient's bilateral, right-sided-predominant symptomatology was not the usual presentation. Typically, the weakness is in the C7-T1 myotome distribution,6 affecting extension, flexion, abduction, and adduction of the fingers and wrist, as well as pronation and supination of the forearm.17 Our patient's weakness was with flexion and extension of the fingers, flexion of the wrist, and extension of the elbow. The atrophy accompanying the muscle weakness, sometimes referred to as oblique amyotrophy,7,18 has a characteristic distribution. It often affects the hand and the ulnar forearm, including the thenar, hypothenar, and interosseous muscles,17 and distinctively spares the brachioradialis muscle.6,8,9 Our patient had atrophy of the hypothenar region and first distal interosseous muscle without the characteristic oblique amyotrophy. Aside from muscle weakness and atrophy, patients can present with tremor-like movements, usually irregular and coarse, of one or a few fingers.17 Symptomatology can worsen with flexion of the neck15 and sometimes with cold temperatures, commonly referred to as cold paresis.12,19 Our patient presented with a very low amplitude tremor of the fingers and with cramps in his right hand, the latter occurring in approximately 30% of patients with Hirayama disease.15

MRI and electrophysiologic studies are usually needed for an accurate diagnosis.6,12 NCSs reveal low ulnar CMAPs that are reduced to a greater extent than those recorded from the median nerve,6,16 as in our patient, along with borderline CMAP amplitude in the left median nerve. Conduction velocity and sensory studies are normal. EMG shows denervation most commonly in C8 to T1 innervated muscles; C7 innervated muscles may show partial involvement. C5-C6 muscles are typically spared and have a normal needle examination. These findings were seen in our patient.

Routine neutral supine cervical spine MRI may appear normal or may reveal nonspecific myelomalacia in the lower cervical spine. As with the symptomatology, the myelomalacia may be asymmetric, typically involving the left more than the right,15,20 with the appearance on axial T2 images commonly referred to as a snake-eye appearance.13 Cervical spine MRI with flexion21 positioning is critical for confidently establishing the diagnosis. With flexion, anterior shifting of the posterior dura mater becomes evident10,22 with enlargement of the posterior cervical epidural space, as well as associated mass effect on the spinal cord compressed anteriorly against the vertebral bodies and typically most pronounced at the level of C5-C6.6,20,23 Our patient had symmetric myelomalacia centered at C5-C6 with a central snake-eye appearance on neutral positioning MRI, and flexion MRI showed expansion of the posterior cervical epidural space with ventral dural displacement and mass effect on the spinal cord.

Hirayama disease has a relatively good prognosis compared to other motor neuron diseases,15 but currently no treatment is available to reverse the weakness.6 Conservative therapy in the form of a cervical collar is typically employed to control progressive symptomatology by preventing the repetitive injury to the spinal cord12 with neck flexion. Patients may use the collar for 3 to 4 years.12 Other mainstays for management are physical and occupational therapy. Surgical fusion has been used in cases refractory to conservative treatment,7,12,23 with the same objective of preventing repetitive neck flexion.23 Cervical duraplasty is an alternative treatment for the disease, as it prevents the abnormal forward displacement of the posterior dura mater while preserving flexion of the cervical spine.24 As is the norm, our patient was prescribed a surgical collar for conservative treatment, with neurosurgical follow-up scheduled to assess his response.

CONCLUSION

Hirayama disease is characterized by compression of the cervical spinal cord by the posterior dura during flexion, resulting in damage to the anterior horn cells. Hirayama disease should be considered in the differential diagnosis for patients in their second or third decade of life with weakness and muscle wasting of the upper extremities, especially males. The application of nonconventional MRI techniques, specifically flexion views, is a key component of establishing the diagnosis and differentiating this disease from other motor neuron pathologies. Immobilization is required to halt disease progression.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care and Medical Knowledge.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

  • ©2020 by the author(s); Creative Commons Attribution License (CC BY)

©2020 by the author(s); licensee Ochsner Journal, Ochsner Clinic Foundation, New Orleans, LA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (creativecommons.org/licenses/by/4.0/legalcode) that permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

REFERENCES

  1. 1.↵
    1. Ay H
    . Hirayama disease (monomelic amyotrophy) clinically confused for carpal tunnel syndrome. Neuropsychiatr Dis Treat. 2017 May 22;13:1385-1388. doi: 10.2147/NDT.S138315.
    OpenUrlCrossRef
  2. 2.↵
    1. Zhou B,
    2. Chen L,
    3. Fan D,
    4. Zhou D
    . Clinical features of Hirayama disease in mainland China. Amyotroph Lateral Scler. 2010;11(1-2):133-139. doi: 10.3109/17482960902912407.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Hirayama K,
    2. Tokumaru Y.
    Cervical dural sac and spinal cord in juvenile muscular atrophy of distal upper extremity. Neurology. 2000 May 23;54(10):1922-1926. doi: 10.1212/wnl.54.10.1922.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. McGregor S,
    2. Joswig H,
    3. Duggal N,
    4. Miller TA
    . Hirayama disease: a diagnostic and therapeutic challenge. Can J Neurol Sci. 2017 Nov;44(6):754-756. doi: 10.1017/cjn.2017.219.
    OpenUrlCrossRef
  5. 5.↵
    1. Hirayama K
    . Juvenile muscular atrophy of unilateral upper extremity-new clinical entity. Psychiatr Neurol Jpn. 1959;61:2190.
    OpenUrl
  6. 6.↵
    1. Foster E,
    2. Tsang BK-T,
    3. Kam A,
    4. Storey E,
    5. Day B,
    6. Hill A
    . Hirayama disease. J Clin Neurosci. 2015 Jun;22(6):951-954. doi: 10.1016/j.jocn.2014.11.025.
    OpenUrlCrossRef
  7. 7.↵
    1. Kieser DC,
    2. Cox PJ,
    3. Kieser SCJ
    . Hirayama disease. Eur Spine J. 2018 Jun;27(6):1201-1206. doi: 10.1007/s00586-018-5545-9.
    OpenUrlCrossRef
  8. 8.↵
    1. Hirayama K
    . Juvenile muscular atrophy of distal upper extremity (Hirayama disease). Intern Med. 2000 Apr;39(4):283-290. doi: 10.2169/internalmedicine.39.283.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hirayama K,
    2. Tomonaga M,
    3. Kitano K,
    4. Yamada T,
    5. Kojima S,
    6. Arai K
    . Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. J Neurol Neurosurg Psychiatry. 1987 Mar;50(3):285-290. doi: 10.1136/jnnp.50.3.285.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Chen CJ,
    2. Chen CM,
    3. Wu CL,
    4. Ro LS,
    5. Chen ST,
    6. Lee TH
    . Hirayama disease: MR diagnosis. AJNR Am J Neuroradiol. 1998 Feb;19(2):365-368.
    OpenUrlAbstract
  11. 11.↵
    1. Huang YL,
    2. Chen CJ
    . Hirayama disease. Neuroimaging Clin N Am. 2011 Nov;21(4):939-950, ix-x. doi: 10.1016/j.nic.2011.07.009.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Lay SE,
    2. Sharma S
    . Hirayama disease (non-progressive juvenile spinal muscular atrophy). StatPearls [Internet]. 2019. www.ncbi.nlm.nih.gov/books/NBK499913/. Published November 14, 2019. Accesed February 21, 2019.
  13. 13.↵
    1. Xu H,
    2. Shao M,
    3. Zhang F,
    4. et al.
    Snake-eyes appearance on MRI occurs during the late stage of Hirayama disease and indicates poor prognosis. Biomed Res Int. 2019 Jan 13;2019:9830243. doi: 10.1155/2019/9830243.
    OpenUrlCrossRef
  14. 14.↵
    1. Preethish-Kumar V,
    2. Polavarapu K,
    3. Nashi S,
    4. et al.
    Hirayama disease/cervical flexion-induced myelopathy progressing to spastic paraparesis: a report on three cases with literature review. Neurol India. 2018 Jul-Aug;66(4):1094-1099. doi: 10.4103/0028-3886.236966.
    OpenUrlCrossRef
  15. 15.↵
    1. Aundhakar SC,
    2. Mahajan SK,
    3. Chhapra DA
    . Hirayama's disease: a rare clinical variant of amyotrophic lateral sclerosis. Adv Biomed Res. 2017 Jul 28;6:95. doi: 10.4103/2277-9175.211797.
    OpenUrlCrossRef
  16. 16.↵
    1. Rosliakova A,
    2. Zakroyshchikova I,
    3. Bakulin I,
    4. et al.
    Hirayama disease: analysis of cases in Russia. Neurol Sci. 2019 Jan;40(1):105-112. doi: 10.1007/s10072-018-3588-7.
    OpenUrlCrossRef
  17. 17.↵
    1. Hirayama K,
    2. Tsubaki T,
    3. Toyokura Y,
    4. Okinaka S
    . Juvenile muscular atrophy of unilateral upper extremity. Neurology. 1963 May;13(5):373-380. doi: 10.1212/WNL.13.5.373.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Gandhi D,
    2. Goyal M,
    3. Bourque PR,
    4. Jain R
    . Case 68: Hirayama disease. Radiology. 2004 Mar;230(3):692-696. doi: 10.1148/radiol.2303021089.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Pradhan S
    . Bilaterally symmetric form of Hirayama disease. Neurology. 2009 Jun 16;72(24):2083-2089. doi: 10.1212/WNL.0b013e3181aa5364.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Tsukita K,
    2. Sakamaki-Tsukita H
    . Hirayama disease: oblique amyotrophy and characteristic magnetic resonance imaging findings. QJM. 2018 Aug 1;111(8):583-584. doi: 10.1093/qjmed/hcy048.
    OpenUrlCrossRef
  21. 21.↵
    1. Boruah DK,
    2. Prakash A,
    3. Gogoi BB,
    4. Yadav RR,
    5. Dhingani DD,
    6. Sarma B
    . The importance of flexion MRI in Hirayama disease with special reference to laminodural space measurements. AJNR Am J Neuroradiol. 2018 May;39(5):974-980. doi: 10.3174/ajnr.A5577.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Lehman VT,
    2. Luetmer PH,
    3. Sorenson EJ,
    4. et al.
    Cervical spine MR imaging findings of patients with Hirayama disease in North America: a multisite study. AJNR Am J Neuroradiol. 2013 Feb;34(2):451-456. doi: 10.3174/ajnr.A3277.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Kuo YH,
    2. Kuo CH,
    3. Huang WC,
    4. Wu JC
    . Anterior cervical discectomy and fusion for Hirayama disease: a case report and literature review. Neurospine. 2019 Sep;16(3):626-630. doi: 10.14245/ns.1836178.089.
    OpenUrlCrossRef
  24. 24.↵
    1. Ito H,
    2. Takai K,
    3. Taniguchi M
    . Cervical duraplasty with tenting sutures via laminoplasty for cervical flexion myelopathy in patients with Hirayama disease: successful decompression of a “tight dural canal in flexion” without spinal fusion. J Neurosurg Spine. 2014 Nov;21(5):743-752. doi: 10.3171/2014.7.SPINE13955.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal: 20 (2)
Ochsner Journal
Vol. 20, Issue 2
Jun 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hirayama Disease in an Adolescent Male With Right Hand Weakness and Muscle Wasting
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hirayama Disease in an Adolescent Male With Right Hand Weakness and Muscle Wasting
Julian Llano, Neil U. Lall, Lamar Davis, Andrew J. Steven
Ochsner Journal Jun 2020, 20 (2) 117-120; DOI: 10.31486/toj.19.0045

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hirayama Disease in an Adolescent Male With Right Hand Weakness and Muscle Wasting
Julian Llano, Neil U. Lall, Lamar Davis, Andrew J. Steven
Ochsner Journal Jun 2020, 20 (2) 117-120; DOI: 10.31486/toj.19.0045
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • INTRODUCTION
    • HISTORY AND CASE REPORT
    • RADIOGRAPHIC APPEARANCE AND TREATMENT
    • DISCUSSION
    • CONCLUSION
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Autoimmune Encephalitis Presenting as Dystonia-Parkinsonism
  • Optimizing Pain Control and Function in Patients With Adhesive Capsulitis by Choosing the Best Injection Site
  • Sacroiliac Joint Pain in the Athlete
Show more QUARTERLY COLUMNS

Similar Articles

Current Post at the Blog

American Association for the Advancement of Science Surveys Scientists About Article Publishing Charges—And Uncovers More Problems

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2023 Ochsner Clinic Foundation

Powered by HighWire